Evidence map›Paper›PMID 31441427›Full record

ArticleEmerging infectious diseases2019

Clinical Characteristics and Treatment Outcomes for Patients Infected with Mycobacterium haemophilum.

Pornboonya Nookeu, Nasikarn Angkasekwinai, Suporn Foongladda, Pakpoom Phoompoung

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Expanding the Clinical Spectrum ofOpen forum infectious diseases · 2026
    Article
  2. Journal of rural medicine : JRM · 2026
    Article
  3. Multifocal Cutaneous and MusculoskeletalCase reports in transplantation · 2026
    Article
  4. Article
  5. BMJ case reports · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Osteomyelitis due toIDCases · 2023
    Article
  11. Article
  12. Disseminated cutaneousBMJ case reports · 2022
    Article
  13. Review
  14. Fatal disseminatedJournal of clinical tuberculosis and other mycobacterial diseases · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. DisseminatedCase reports in ophthalmology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pornboonya Nookeu
Nasikarn Angkasekwinai
Suporn Foongladda
Pakpoom Phoompoung
Siriraj Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium haemophilum is a nontuberculous mycobacterium that can infect immunocompromised patients. Because of special conditions required for its culture, this bacterium is rarely reported and there are scarce data for long-term outcomes. We conducted a retrospective study at Siriraj Hospital, Bangkok, Thailand, during January 2012-September 2017. We studied 21 patients for which HIV infection was the most common concurrent condition. The most common organ involvement was skin and soft tissue (60%). Combination therapy with macrolides and fluoroquinolones resulted in a 60% cure rate for cutaneous infection; adding rifampin as a third drug for more severe cases resulted in modest (66%) cure rate. Efficacy of medical therapy in cutaneous, musculoskeletal, and ocular diseases was 80%, 50%, and 50%, respectively. All patients with central nervous system involvement showed treatment failures. Infections with M. haemophilum in HIV-infected patients were more likely to have central nervous system involvement and tended to have disseminated infections and less favorable outcomes.

Indexed as

HIV InfectionsImmunocompromised HostAdultAgedAnti-Bacterial AgentsCohort StudiesFemaleHumansMaleMiddle AgedMycobacterium haemophilumMycobacterium InfectionsRetrospective StudiesThailandTreatment OutcomeAnti-Bacterial AgentsbacteriaBangkokclinical characteristicsinfectionMycobacterium haemophilumnontuberculous mycobacteriaThailandtreatment outcomestuberculosis and other mycobacteria

Identifiers

PMID31441427
PMCPMC6711220
OpenAlexW2965860541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.